Last updated: 15 March 2023 at 2:21pm EST

Steven Reichling Net Worth




The estimated Net Worth of Steven Reichling is at least $237 millier dollars as of 13 March 2023. Steven Reichling owns over 9,438 units of Accelerate Diagnostics Inc stock worth over $236,796 and over the last 10 years Steven sold AXDX stock worth over $0.

Steven Reichling AXDX stock SEC Form 4 insiders trading

Steven has made over 16 trades of the Accelerate Diagnostics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Steven exercised 9,438 units of AXDX stock worth $15,195 on 13 March 2023.

The largest trade Steven's ever made was exercising 123,600 units of Accelerate Diagnostics Inc stock on 8 March 2023 worth over $198,996. On average, Steven trades about 13,737 units every 94 days since 2014. As of 13 March 2023 Steven still owns at least 147,078 units of Accelerate Diagnostics Inc stock.

You can see the complete history of Steven Reichling stock trades at the bottom of the page.



What's Steven Reichling's mailing address?

Steven's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.

Insiders trading at Accelerate Diagnostics Inc

Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg et Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.



What does Accelerate Diagnostics Inc do?

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.



What does Accelerate Diagnostics Inc's logo look like?

Accelerate Diagnostics Inc logo

Complete history of Steven Reichling stock trades at Accelerate Diagnostics Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
13 Mar 2023 Steven Reichling
Directeur financier
Exercice d'option 9,438 $5.10 $48,134
13 Mar 2023
147,078
8 Mar 2023 Steven Reichling
Directeur financier
Exercice d'option 123,600 $4.72 $583,392
8 Mar 2023
200,418
13 Feb 2023 Steven Reichling
Directeur financier
Exercice d'option 9,439 $6.10 $57,578
13 Feb 2023
81,641
13 Jan 2023 Steven Reichling
Directeur financier
Exercice d'option 9,439 $7.20 $67,961
13 Jan 2023
76,932
22 Aug 2022 Steven Reichling
Directeur financier
Acheter 5,000 $1.39 $6,950
22 Aug 2022
67,493
26 Apr 2022 Steven Reichling
Directeur financier
Exercice d'option 57,736 $10.40 $600,454
26 Apr 2022
92,408
12 May 2021 Steven Reichling
Directeur financier
Exercice d'option 27,392 $70.00 $1,917,440
12 May 2021
42,975
25 Jan 2021 Steven Reichling
Directeur financier
Exercice d'option 70,671 $2.98 $210,600
25 Jan 2021
38,300
16 Dec 2020 Steven Reichling
Directeur financier
Exercice d'option 3,142 $75.20 $236,278
16 Dec 2020
16,442
9 Nov 2020 Steven Reichling
Directeur financier
Exercice d'option 39,329 $2.98 $117,200
9 Nov 2020
52,629
19 Mar 2020 Steven Reichling
Directeur financier
Acheter 1,000 $6.92 $6,920
19 Mar 2020
13,300
27 Feb 2020 Steven Reichling
Directeur financier
Exercice d'option 10,000 $2.98 $29,800
27 Feb 2020
12,300
27 Nov 2018 Steven Reichling
Directeur financier
Acheter 850 $13.13 $11,161
27 Nov 2018
2,300
8 Nov 2018 Steven Reichling
Directeur financier
Acheter 750 $14.72 $11,040
8 Nov 2018
1,450
21 Jun 2017 Steven Reichling
Directeur financier
Exercice d'option 30,000 $2.98 $89,400
21 Jun 2017
30,700
29 Sep 2015 Steven Reichling
Directeur financier
Acheter 600 $15.23 $9,138
29 Sep 2015
700


Accelerate Diagnostics Inc executives and stock owners

Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include: